These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11078416)

  • 21. Antihypertensive treatment with enrasentan (SB217242) in an animal model of hypertension and hyperinsulinemia.
    Cosenzi A; Bernobich E; Bonavita M; Bertola G; Trevisan R; Bellini G
    J Cardiovasc Pharmacol; 2002 Apr; 39(4):488-95. PubMed ID: 11904522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670.
    Brooks DP; Contino LC
    Eur J Pharmacol; 1995 Dec; 294(2-3):571-6. PubMed ID: 8750720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
    Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
    Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
    Bunting MW; Widdop RE
    Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of nitric oxide.
    Gellai M; De Wolf R; Fletcher T; Nambi P
    Pharmacology; 1997 Dec; 55(6):299-308. PubMed ID: 9413859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of renal vasodilation after administration of atrial natriuretic factor in the conscious dog.
    Hintze TH
    Hypertension; 1988 Aug; 12(2):143-51. PubMed ID: 2970433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired response of the denervated kidney to endothelin receptor blockade in normotensive and spontaneously hypertensive rats.
    Girchev R; Bäcker A; Markova P; Kramer HJ
    Kidney Int; 2004 Mar; 65(3):982-9. PubMed ID: 14871418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional role of ETB receptors in the renal medulla.
    Vassileva I; Mountain C; Pollock DM
    Hypertension; 2003 Jun; 41(6):1359-63. PubMed ID: 12719443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal interstitial hydrostatic pressure during verapamil-induced natriuresis.
    Granger JP; Solhaug MJ
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R432-6. PubMed ID: 1558213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SB 209670 inhibits the arrhythmogenic actions of endothelin-1 in the anesthetized dog.
    Douglas SA; Nichols AJ; Feuerstein GZ; Elliott JD; Ohlstein EH
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S99-102. PubMed ID: 9595411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs.
    Takagi H; Takahara A; Tomura Y; Yamagata T; Hisa H; Satoh S
    J Pharmacol Exp Ther; 1993 Oct; 267(1):456-61. PubMed ID: 8229776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of renal arterial endothelin-1 and endogenous endothelins on regional kidney blood flow and renal antihypertensive mechanisms in anesthetized rabbits.
    Weekes SR; Madden AC; Bergström G; Anderson WP; Evans RG
    Kidney Blood Press Res; 2000; 23(6):366-75. PubMed ID: 11070416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natriuretic effect of non-pressor doses of endothelin-1 in conscious dogs.
    Sandgaard NC; Bie P
    J Physiol; 1996 Aug; 494 ( Pt 3)(Pt 3):809-18. PubMed ID: 8865076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic activation of endothelin B receptors: new model of experimental hypertension.
    Fink G; Li M; Lau Y; Osborn J; Watts S
    Hypertension; 2007 Sep; 50(3):512-8. PubMed ID: 17664390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.
    Douglas SA; Edwards RM; Elliott JD; Ohlstein EH
    Br J Pharmacol; 1995 Jan; 114(2):405-13. PubMed ID: 7881741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovariectomy uncovers purinergic receptor activation of endothelin-dependent natriuresis.
    Gohar EY; Kasztan M; Becker BK; Speed JS; Pollock DM
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F361-F369. PubMed ID: 28468962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal actions of endothelin: interaction with prostacyclin.
    Chou SY; Dahhan A; Porush JG
    Am J Physiol; 1990 Oct; 259(4 Pt 2):F645-52. PubMed ID: 2221102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of NKH477 on endothelin-1-induced renal responses in anaesthetized dogs.
    Hara S; Tanahashi M; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
    Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):513-5. PubMed ID: 10874508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of endothelin in mediating the attenuated renal hemodynamics in Dahl salt-sensitive hypertension.
    Kassab S; Novak J; Miller T; Kirchner K; Granger J
    Hypertension; 1997 Sep; 30(3 Pt 2):682-6. PubMed ID: 9323005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction.
    Willette RN; Anderson KM; Nelson AH; Olzinski AR; Woods T; Coatney RW; Aiyar N; Ohlstein EH; Barone FC
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):606-17. PubMed ID: 11588531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.